ARS Pharmaceuticals SPRY
NASDAQ SPRY
$4.12 -0.19 (-4.41%)
At close: Oct 1, 2026 · 4:00 PM EDT

ARS Pharmaceuticals (SPRY) Net Equity Issued and Repurchased (2020 - 2026)

Updated

ARS Pharmaceuticals (SPRY) reported Net Equity Issued and Repurchased of $786,000 for Q2 2026, down 70.9% from $2.7 million a year earlier.

Analysis

ARS Pharmaceuticals (SPRY) Net Equity Issued and Repurchased (2020 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, ARS Pharmaceuticals' Net Equity Issued and Repurchased came in at $3.11 million, down 44.9% year-over-year; for FY2025, it came in at $5.68 million, up 88.4% from FY2024.

  • Net Equity Issued and Repurchased has a five-year compound annual growth rate of -53.4% (FY2020 to FY2025).
  • By year, Net Equity Issued and Repurchased came in at $3.02 million in FY2024 (-56.3%), $6.9 million in FY2023, $570,000 in FY2022 (-99.0%) and $54.81 million in FY2021 (-78.8%).
  • Five-year quarterly Net Equity Issued and Repurchased spans a low of $62,000 in Q1 2026 and a high of $53.62 million in Q4 2021.
  • Year over year, Net Equity Issued and Repurchased gained in three of the last eight quarters, with growth averaging 44.9%.
  • The high point for year-over-year Net Equity Issued and Repurchased in five years was Q2 2023 (growth of 894.4%); the low point was Q3 2021 (a decline of 99.9%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $62,000 (Q1 2026), $1.78 million (Q4 2025) and $479,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 ARS Pharmaceuticals 428.58 Mn 284.78 Mn 20.81 Mn 786,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 786,000.00
Mar 31, 2026 62,000.00
Dec 31, 2025 1.78 Mn
Sep 30, 2025 479,000.00
Jun 30, 2025 2.70 Mn
Mar 31, 2025 725,000.00
Dec 31, 2024 1.53 Mn
Sep 30, 2024 680,000.00
Jun 30, 2024 545,000.00
Mar 31, 2024 258,000.00
Dec 31, 2023 1.81 Mn
Sep 30, 2023 921,000.00
Jun 30, 2023 2.85 Mn
Mar 31, 2023 1.32 Mn
Dec 31, 2022 283,000.00
Jun 30, 2022 287,000.00
Dec 31, 2021 53.62 Mn
Sep 30, 2021 148,000.00
Jun 30, 2021 815,000.00
Mar 31, 2021 222,000.00
API Access

ARS Pharmaceuticals Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=SPRY&period=max&api_key=YOUR_API_KEY